Literature DB >> 6899736

Elastase and lysozyme activities in human alveolar macrophages. Effects of cigarette smoking.

L M Hinman, C A Stevens, R A Matthay, J B Gee.   

Abstract

We compared the elastase and lysozyme activities of cells obtained by bronchoalveolar lavage from normal smokers and nonsmokers. After total and differential cell counts were obtained for the initial lavage cell population, we determined the enzyme activities of the total lavage cell population, the culture vessel's adherent alveolar macrophage cell fraction, and the cell culture supernatant medium. Our data indicated that macrophages, particularly from smokers, synthesized a calcium-dependent activity against a synthetic elastase substrate, succinyl-trialanine-p-nitroanilide. This activity was enhanced in smokers and was distinct from the polymorphonuclear leukocyte elastase as measured with this synthetic substrate. Measurements using insoluble elastin labeled with 3H demonstrated that smokers' macrophages also contained a serine-proteinase activity whose inhibitor profile resembled that of polymorphonuclear leukocyte elastase. Finally, macrophages from smokers secreted 5 times more lysozyme and contained more lactate dehydrogenase activity than did nonsmokers' macrophages. We suggest that pulmonary macrophages take up the polymorphonuclear leukocyte elastase and contain a synthetic substrate, "elastase". The biologic significance of this elastase activity is unclear. The enhanced lysozyme secretion by smokers' alveolar macrophages indicated increased biosynthetic activity by these cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6899736     DOI: 10.1164/arrd.1980.121.2.263

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  23 in total

1.  Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.

Authors:  Ellen L Burnham; Jeanette Gaydos; Edward Hess; Robert House; Jacinta Cooper
Journal:  Alcohol Alcohol       Date:  2010-08-20       Impact factor: 2.826

2.  Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.

Authors:  R R Kew; B Ghebrehiwet; A Janoff
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

3.  Smoking before surgery: the case for stopping.

Authors:  R M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

4.  Enzymatic activities of bronchoalveolar lavages in coal workers pneumoconiosis.

Authors:  B Sablonniere; A Scharfman; J J Lafitte; A Laine; C Aerts; A Hayem
Journal:  Lung       Date:  1983       Impact factor: 2.584

5.  Elastolytic activity of alveolar macrophages in chronic bronchitis: comparison of current and former smokers.

Authors:  S O'Neill; J S Prichard
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

6.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity.

Authors:  T Masubuchi; S Koyama; E Sato; A Takamizawa; K Kubo; M Sekiguchi; S Nagai; T Izumi
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells.

Authors:  R M Senior; E J Campbell; J A Landis; F R Cox; C Kuhn; H S Koren
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

9.  Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.

Authors:  H A Chapman; O L Stone; Z Vavrin
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.

Authors:  R B Fick; G P Naegel; R A Matthay; H Y Reynolds
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.